Skip to main content
Home

Main navigation

  • Home
  • News
  • About HIV
  • About us
Search
Donate
Donate now

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you.

I am a UK taxpayer and I understand that if I pay less Income and /or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in the relevant tax year, it is my responsibility to pay any difference.

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness.

  • £5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment.
  • £10 helps us produce news and bulletins on the latest developments in HIV for healthcare staff around the world.
  • £35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts.

Showing 6 results

Filters Content type: Editors' picks Conference: International Liver Congress - 2013
New & experimental hepatitis C treatment

Gilead-Bristol Hepatitis C Combo Cures 100% of Patients in Study

Editor's pick
Businessweek
28 April 2013
New & experimental hepatitis C treatment

Sofosbuvir Offers High Cure Rate For Two Hepatitis C Subtypes -

Editor's pick
Medical News Today
24 April 2013
New & experimental hepatitis C treatment

Investigational compound faldaprevir shows high viral cure and early treatment success in treatment-naïve patients with genotype-1 hepatitis C

Editor's pick
Boehringer-Ingelheim press release
24 April 2013
New & experimental hepatitis C treatment

Medivir: New Data from Simeprevir Phase III Studies Quest 1 and 2 in Hepatitis C Patients will be Presented at EASL 23-28 April in Amsterdam Read more: Medivir: New Data from Simeprevir Phase III Studies Quest 1 and 2 in Hepatitis C Patients will be Pres

Editor's pick
Medivir press release
24 April 2013
New & experimental hepatitis C treatment

AbbVie hepatitis C drugs knock out virus at eight weeks

Editor's pick
Yahoo News
24 April 2013
New & experimental hepatitis C treatment

Bristol-Myers oral hepatitis C regimen looks competitive -study

Editor's pick
Reuters
24 April 2013

Refine search

By content type
From
To
Topic

About us

NAM is a charity based in the United Kingdom. We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital in the fight against HIV & AIDS.

Our information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

Read more about us

Connect with us

  • Twitter
  • Facebook
  • YouTube
  • Instagram
Subscribe to emails & newsfeeds

Login to our clinic portal
Donate

Visit NAM’s other websites: clinic.nam.org.uk | infohep.org | prepineurope.org | about-hiv.info | pro-vich.info | hiv-lens.org

© NAM Publications 2022, all rights reserved. NAM is not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
  • Jobs
  • Terms of Use
  • Accessibility
  • Privacy Policy
  • Cookies
  • Manage cookies